BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25502391)

  • 1. MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study.
    Bansal A; Hong X; Lee IH; Krishnadath KK; Mathur SC; Gunewardena S; Rastogi A; Sharma P; Christenson LK
    Clin Transl Gastroenterol; 2014 Dec; 5(12):e65. PubMed ID: 25502391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
    J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
    Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
    Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
    Wijnhoven BP; Hussey DJ; Watson DI; Tsykin A; Smith CM; Michael MZ;
    Br J Surg; 2010 Jun; 97(6):853-61. PubMed ID: 20301167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
    Sharma P
    Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
    Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
    Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; HenrĂ­quez A
    Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features.
    Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
    Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of Barrett's oesophagus.
    Van Eyken P
    Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF; Krishnan K; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
    El-Zimaity HM; Graham DY
    Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of intestinal metaplasia in the gastric cardia.
    El-Serag HB; Sonnenberg A; Jamal MM; Kunkel D; Crooks L; Feddersen RM
    Am J Gastroenterol; 1999 Mar; 94(3):622-7. PubMed ID: 10086641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular miRNAs for the Management of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review.
    Inokuchi K; Ochiya T; Matsuzaki J
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.